Ascendis Pharma A (ASND) Total Non-Current Liabilities (2019 - 2026)
Ascendis Pharma A (ASND) recorded Total Non-Current Liabilities of $447.09 million in the quarter ended Jun 30, 2026, up 16.0% from $385.4 million a year earlier but down 1.7% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A reported Total Non-Current Liabilities of $447.41 million, up 13.2% from the prior year.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 377.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Total Non-Current Liabilities came in at $395.14 million in the year ended Dec 31, 2024 (+55.6%), $253.96 million in the year ended Dec 31, 2023 (-63.2%), $690.47 million in the year ended Dec 31, 2022 (+516.1%) and $112.07 million in the year ended Dec 31, 2021.
- Quarterly Total Non-Current Liabilities has ranged from $112.07 million in the quarter ended Dec 31, 2021 to $798.9 million in the quarter ended Sep 30, 2023 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has increased for seven consecutive quarters, with growth averaging 20.0% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 532.7% in the quarter ended Mar 31, 2022, against a decline of 62.2% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $454.89 million (quarter ended Mar 31, 2026), $460.96 million (quarter ended Dec 31, 2025) and $400.22 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 447.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 447.09 Mn |
| Mar 31, 2026 | 454.89 Mn |
| Dec 31, 2025 | 460.96 Mn |
| Sep 30, 2025 | 400.22 Mn |
| Jun 30, 2025 | 385.40 Mn |
| Mar 31, 2025 | 384.71 Mn |
| Dec 31, 2024 | 390.12 Mn |
| Sep 30, 2024 | 387.28 Mn |
| Jun 30, 2024 | 249.51 Mn |
| Mar 31, 2024 | 262.59 Mn |
| Dec 31, 2023 | 252.60 Mn |
| Sep 30, 2023 | 798.90 Mn |
| Jun 30, 2023 | 617.10 Mn |
| Mar 31, 2023 | 644.77 Mn |
| Dec 31, 2022 | 668.38 Mn |
| Sep 30, 2022 | 684.65 Mn |
| Jun 30, 2022 | 644.35 Mn |
| Mar 31, 2022 | 683.59 Mn |
| Dec 31, 2021 | 112.07 Mn |
| Sep 30, 2021 | 112.68 Mn |
API Access
Ascendis Pharma A Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();